v3.20.1
Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
OPERATING ACTIVITIES    
Net loss $ (774,550) $ (1,123,933)
Stock-based compensation-product development costs 79 337
Stock-based compensation-general, selling and administration 264,656
Stock-based compensation-professional fees 199,192
Non-cash imputed interest expense 30,319 30,425
Accrued interest on line of credit 356,454 333,250
Changes in assets and liabilities:    
Increase (decrease) in accounts payable and accrued liabilities 35,084 (5,952)
Increase in interest payable 132,218 132,217
Net cash used in operating activities (220,396) (169,808)
FINANCING ACTIVITIES    
Proceeds from borrowings on line of credit 218,908 166,815
Net cash provided by financing activities 218,908 166,815
Increase (decrease) in cash (1,488) (2,993)
Cash, beginning of year 1,838 3,378
Cash, end of year $ 350 $ 385